Hypoxia-inducible factor-1α (HIF-1α) and Photodynamic Therapy
Journal
Second Asian and Pacific Rim Symposium on Biophotonics - Proceedings, APBP 2004
Pages
88
Date Issued
2004
Author(s)
Abstract
The use of photodynamic therapy (PDT) that is considered as a promising treatment in the clinic for use in oncology was discussed. PDT requires three elements mainly light, a photosensitizer and oxygen. It was found that PDT could transcriptionally induce or enhance hypoxia-inducible factor - 1α (HIF-1α) expression in different cervical cancer cell lines, immortalized cervical epithelium cell line 183A and human umbilical vein endothelial cells (HUVEC). PDT activated HIF - 1α protein expression was markedly inhibited and subsequently sensitized SiHa cells to PDT. The results provided important information to improve the therapeutic efficacy and had great clinical applicable potential.
SDGs
Other Subjects
Bioassay; Blood; Cells; Diseases; Genes; Light emitting diodes; Oncology; Patient monitoring; Photosensitizers; Physiological models; Tissue; Tumors; Cancer cells; Endothelial cells; Gene activation; Human umbilical vein endothelial cells (HUVEC); Microvascular injury; Photodynamic therapy
Type
conference paper